4.67
0.28 (6.38%)
| Previous Close | 4.39 |
| Open | 4.39 |
| Volume | 2,010,503 |
| Avg. Volume (3M) | 751,384 |
| Market Cap | 327,883,520 |
| Price / Earnings (Forward) | 19.16 |
| Price / Sales | 0.870 |
| Price / Book | 0.850 |
| 52 Weeks Range | |
| Earnings Date | 7 May 2025 - 12 May 2025 |
| Profit Margin | -22.67% |
| Operating Margin (TTM) | -18.60% |
| Diluted EPS (TTM) | -1.15 |
| Quarterly Revenue Growth (YOY) | 6.00% |
| Total Debt/Equity (MRQ) | 110.15% |
| Current Ratio (MRQ) | 1.43 |
| Operating Cash Flow (TTM) | 14.56 M |
| Levered Free Cash Flow (TTM) | 29.45 M |
| Return on Assets (TTM) | -4.57% |
| Return on Equity (TTM) | -18.99% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Mixed | Mixed |
| Health Information Services (Global) | Mixed | Mixed | |
| Stock | Health Catalyst, Inc | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 5.0 |
| Technical Oscillators | -2.5 |
| Average | 1.50 |
|
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 3.50% |
| % Held by Institutions | 76.54% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Daventry Group, Lp | 31 Dec 2024 | 2,509,480 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 10.00 (Canaccord Genuity, 114.13%) | Buy |
| 10.00 (Wells Fargo, 114.13%) | Buy | |
| 10.00 (Citigroup, 114.13%) | Buy | |
| Median | 8.50 (82.01%) | |
| Low | 5.00 (Stephens & Co., 7.07%) | Hold |
| 5.00 (Stifel, 7.07%) | Hold | |
| Average | 7.88 (68.74%) | |
| Total | 5 Buy, 3 Hold | |
| Avg. Price @ Call | 5.54 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Stephens & Co. | 06 Mar 2025 | 5.00 (7.07%) | Hold | 4.43 |
| 27 Feb 2025 | 7.00 (49.89%) | Hold | 4.39 | |
| RBC Capital | 27 Feb 2025 | 6.00 (28.48%) | Hold | 4.39 |
| 15 Jan 2025 | 7.00 (49.89%) | Hold | 5.76 | |
| Stifel | 27 Feb 2025 | 5.00 (7.07%) | Hold | 4.39 |
| Piper Sandler | 11 Feb 2025 | 8.00 (71.31%) | Buy | 5.50 |
| Canaccord Genuity | 21 Jan 2025 | 10.00 (114.13%) | Buy | 5.68 |
| Wells Fargo | 21 Jan 2025 | 10.00 (114.13%) | Buy | 5.68 |
| Citigroup | 10 Jan 2025 | 10.00 (114.13%) | Buy | 6.89 |
| Keybanc | 08 Jan 2025 | 9.00 (92.72%) | Buy | 7.36 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |